Revolution Medicines, Inc. <RVMD.O>: Wedbush Raises Target Price to $225 From $201
RVMD•Related News
Kymera Therapeutics, Inc. <KYMR.O>: Wells Fargo Raises Target Price to $151 From $116
KYMR•
TD declares quarterly dividend of CAD 1.12 per common share
TD•
Okta, Inc. <OKTA.O>: Morgan Stanley raises target price to $200.00 from $180.00
OKTA•
The J. M. Smucker Company: Stifel raises target price to $132 from $115
SJM•
Eton Pharmaceuticals hosts one-on-one investor meetings at Wells Fargo Healthcare Conference
ETON•